Up a level |
(2023) HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer. Cancer Nanotechnology.
(2023) Identification of potential key genes linked to gender differences in bladder cancer based on gene expression omnibus (GEO) database. Advanced Biomedical Research. p. 157.
(2023) Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer. Nanomedicine. 259 – 277.